Welcome to Paid Research Studies




  • Condition:   Chronic Fatigue Syndrome
    Intervention:   Drug: Poly I: Poly C12U (Rintatolimod)
    Sponsor:   Hemispherx Biopharma
    Available

  • Conditions:   Metastatic Carcinoma in the Liver;   Recurrent Colorectal Carcinoma;   Stage IV Colorectal Cancer AJCC v7;   Stage IVA Colorectal Cancer AJCC v7;   Stage IVB Colorectal Cancer AJCC v7
    Interventions:   Drug: Celecoxib;   Other: Laboratory Biomarker Analysis;   Biological: Recombinant Interferon Alfa-2b;   Drug: Rintatolimod
    Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Ovarian Cancer Recurrent
    Interventions:   Drug: Rintatolimod;   Drug: Pembrolizumab;   Drug: Cisplatin
    Sponsors:   Robert Edwards;   Hemispherx Biopharma;   Merck Sharp & Dohme Corp.
    Recruiting

  • Conditions:   Prostate Adenocarcinoma;   Stage I Prostate Cancer AJCC v8;   Stage II Prostate Cancer AJCC v8;   Stage IIA Prostate Cancer AJCC v8;   Stage IIB Prostate Cancer AJCC v8;   Stage IIC Prostate Cancer AJCC v8;   Stage III Prostate Cancer AJCC v8;   Stage IIIA Prostate Cancer AJCC v8;   Stage IIIB Prostate Cancer AJCC v8;   Stage IIIC Prostate Cancer AJCC v8
    Interventions:   Drug: Aspirin;   Procedure: Radical Prostatectomy;   Biological: Recombinant Interferon Alfa-2b;   Drug: Rintatolimod
    Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI);   Hemispherx Biopharma
    Not yet recruiting

  • Conditions:   Triple -Negative Breast Cancer;   Estrogen Receptor Negative;   HER2/Neu Negative;   Anatomic Stage IV Breast Cancer AJCC;   Progesterone Receptor Negative
    Interventions:   Procedure: Biopsy;   Procedure: Chemokine Modulation Therapy;   Drug: Celecoxib;   Biological: Recombinant Interferon Alfa-2b;   Drug: Rintatolimod;   Biological: Pembrolizumab
    Sponsor:   Roswell Park Cancer Institute
    Recruiting

  • Conditions:   Cancer of Ovary;   Cancer of the Ovary;   Neoplasms, Ovarian;   Ovarian Cancer;   Ovary Cancer;   Ovary Neoplasms
    Interventions:   Biological: Cisplatin + celecoxib + DC vaccine;   Biological: Cisplatin + CKM + Celecoxib + DC Vaccine
    Sponsors:   Roswell Park Cancer Institute;   Hemispherx Biopharma;   National Cancer Institute (NCI);   University of Pittsburgh
    Recruiting